Vancomycin therapy of bacterial meningitis.
D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D001769:Blood / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D004352:Drug Resistance, Microbial; D005260:Female; D005417:Flavobacterium / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008581:Meningitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D008826:Microbial Sensitivity Tests; D010614:Pharynx / Q000382:microbiology; D012640:Seizures / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013997:Time Factors; D014640:Vancomycin / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000627:therapeutic use*
D002556:Cerebrospinal Fluid Proteins; D014640:Vancomycin